Abstract
Introduction
Gonorrhoea and chlamydia cases have been rising among gay, bisexual and other men who have sex with men (MSM) over the last decade. The majority of cases are extragenital and occur at the oropharynx and anorectum. The aim of this narrative review was to review the risk factors and mode of transmission for gonorrhoea and chlamydia at the oropharynx and anorectum among MSM.
Results and discussion
New evidence suggests that oropharyngeal gonorrhoea can be transmitted by kissing in addition to through the established route of condomless oral sex; and anorectal gonorrhoea can be acquired when saliva is used as a lubricant for anal sex and rimming in addition to the established route of condomless penile‐anal sex in MSM. In contrast, condomless penile‐anal sex remains the major route for chlamydia transmission.
Conclusions
Substantial transmission of gonorrhoea may occur with practices other than the established routes of condomless oral and/or anal sex and hence condoms may not be effective in preventing gonorrhoea transmission to extragenital sites. In contrast, condoms are effective for chlamydia control because it is mainly transmitted through condomless penile‐anal sex. Novel interventions for gonorrhoea that reduce the risk of transmission at extragenital site are required.
Keywords: Neisseria gonorrhoeae, Chlamydia trachomatis, transmission, men who have sex with men, control, sexual behaviours, sexual practices, saliva, kissing, throat, anal, sexually transmitted infections, sexually transmitted diseases
1. Introduction
Sexually transmitted infections (STIs), are increasing globally, particularly in gay, bisexual and other men who have sex with men (MSM) 1, 2, 3, 4, 5. To address these rises, there have been many novel campaigns and interventions for STIs but these interventions have not been associated with effective STI control in MSM 6, 7, 8, 9, 10, 11. The failure of these campaigns and interventions to reduce STIs could be due to several reasons including that they are not reaching the core group, or because they are based on an incomplete understating of how infections are transmitted. The control of STIs may be more difficult with the introduction of treatment as prevention (TasP) and HIV pre‐exposure prophylaxis (PrEP) which has successfully reduced new incident HIV in MSM but has been associated with changes in sexual practices that increase STI risk 12, 13, 14. In this context, it is time to revisit our understanding of how infections are transmitted with the aim of designing new effective interventions to improve STI control.
Both gonorrhoea and chlamydia until recently were thought to be mainly transmitted through condomless penetrative intercourse such as penile‐vaginal, penile‐anal and oral sex 15, 16, 17, 18, 19, 20, 21, 22, 23. However, in the context of rising STI rates and ineffective interventions, it is important to review the transmission of both infections particularly at extragenital sites in MSM which are largely asymptomatic 24, 25, 26, 27. Other anal sexual activities such as fingering, fisting and rimming are commonly practiced among MSM and may play an important role in transmission 28, 29, 30. Several epidemiological studies have found these activities are associated with the acquisition of any STIs (that is, gonorrhoea, chlamydia or syphilis) in MSM; 28, 31, 32 however, there are limited studies examining the role of these practices in the transmission of gonorrhoea and chlamydia independently. The aim of this narrative review was to revisit the transmission of gonorrhoea and chlamydia to the oropharynx and anorectum in MSM. Several reviews have already described the prevalence and epidemiology of gonorrhoea and chlamydia, behavioural and social risk factors, and possible interventions; 1, 4, 17, 33, 34, 35 and thus these areas will not be covered in this review.
2. Results and discussion
2.1. Prevalence of extragenital gonorrhoea and chlamydia in MSM
Many epidemiological studies have reported on the point prevalence of extragenital gonorrhoea and chlamydia in MSM. Chan and colleagues published a review in 2016 summarising the prevalence of extragenital gonorrhoea and chlamydia from 53 studies (Table 1); 17 however, these estimates vary substantially across geographical regions and study settings. Overall, the authors reported that the median prevalence of gonorrhoea at the oropharynx (4.6%) was similar to the anorectum (5.9%). In contrast, the median prevalence of chlamydia in the anorectum (8.9%) was much higher than in the oropharynx (1.7%).
Table 1.
STI | Prevalence (%) | |
---|---|---|
Median | Range | |
Oropharyngeal gonorrhoea | 4.6% | 0.5% to 16.5% |
Oropharyngeal chlamydia | 1.7% | 0% to 3.6% |
Anorectal gonorrhoea | 5.9% | 0.2% to 24.0% |
Anorectal chlamydia | 8.9% | 2.1% to 23.0% |
Note. Data were obtained from a review of 53 studies published by Chan et al. (2016) 17.
Several studies have compared the prevalence of extragenital gonorrhoea and chlamydia in MSM by HIV status. A US study reported that HIV‐positive MSM had a higher prevalence of anorectal gonorrhoea (8.2% vs. 3.3%) and anorectal chlamydia (9.0% vs. 6.6%) than HIV‐negative MSM; however, the prevalence was similar in both groups for oropharyngeal infection (that is oropharyngeal gonorrhoea: 5.2% in HIV‐positive vs. 4.3% in HIV‐negative; oropharyngeal chlamydia: 1.6% in HIV‐positive vs. 1.3% in HIV‐negative) 15. These findings are consistent with another study conducted in Melbourne, Australia, showing that the prevalence of anorectal gonorrhoea was higher in HIV‐positive MSM (15.4%) than in HIV‐negative MSM (7.3%) but the prevalence of oropharyngeal gonorrhoea was similar in both in HIV‐positive MSM (9.9%) and HIV‐negative MSM (8.1%) 36.
2.2. Oropharyngeal gonorrhoea
Oropharyngeal gonorrhoea is relatively short lived and commonly asymptomatic 7, 25, 37, 38, 39. A natural history study of 18 individuals (12 men and six women) with untreated oropharyngeal gonorrhoea has suggested that the majority of oropharyngeal gonorrhoea infections clear by six weeks and all by 12 weeks 39. Another natural history study of 60 untreated individuals with positive oropharyngeal gonorrhoea culture has shown that more than half (55%) of oropharyngeal gonorrhoea infections clear within seven days 40. Other epidemiological studies also support the short duration of oropharyngeal gonorrhoea 24, 38, 41. However, length time bias may have occurred due to the detection of prevalent infection in these studies.
Oropharyngeal gonorrhoea had been thought to be primarily acquired from oro‐genital contact such as condomless fellatio (Table 2) 24, 42. Fellatio is commonly practiced among MSM (that is, 72.7% of MSM had fellatio with their last male partner) and condoms are rarely used for fellatio in MSM 43, 44.
Table 2.
Studies of symptoms associated with urethral gonorrhoea have been contradictory. In the 1970s, two studies have reported that about 40% of heterosexual men reporting contact with their female partners with gonorrhoea had asymptomatic urethral gonorrhoea 45, 46. However, other studies report that at least 90% of men with urethral gonorrhoea are symptomatic 26, 27, 47, and develop dysuria and urethral discharge within two to five days of exposure 47, 48.
In countries with good access to healthcare, men with symptomatic urethral gonorrhoea usually receive treatment within a few days of the onset of symptoms 49. In this context, the point prevalence of urethral gonorrhoea is estimated to be relatively low in the MSM population (approximately 0.2% 50) compared to the extragenital sites; and hence, this has led some investigators to question whether urethral infection alone could be responsible for the high incidence of oropharyngeal gonorrhoea (26 per 100 person‐years) 50. This is consistent with the observation by Passaro (2018) who reported the prevalence of oropharyngeal gonorrhoea did not differ between MSM who had receptive oral‐penile sex (10.3%) and those who did not (9.8%) 20. Indeed some investigators have hypothesized that the oropharynx may be a more important anatomical site for gonorrhoea transmission in MSM than the urethra 50, 51.
These same investigators have undertaken a series of studies related to their hypothesis. They undertook a study of 33 MSM with untreated culture positive oropharyngeal gonorrhoea and obtained saliva samples from these men up to 14 days after screening 52. The study found that all men (100%) tested positive for Neisseria gonorrhoeae in saliva by nucleic acid amplification test (NAAT) and almost half (43%) of men where their saliva samples were detected by culture 52, 53. In addition, two past studies in the 1970s and 1980s have also found that gonorrhoea can be cultured from saliva but the estimates ranged between 8% 54 and 67% 40. Furthermore, these findings raise the question of whether oropharyngeal gonorrhoea could potentially be transmitted between the oropharynges through kissing, and also between the oropharynx and the anorectum through rimming (Table 2) 21, 22, 41, 50.
Several case reports purposed kissing could be a risk factor for oropharyngeal gonorrhoea in the 1970s 37, 54, 55. In these early studies, cases were diagnosed using culture, which has poor sensitivity and specificity for Neisseria gonorrhoeae in the oropharynx. Rather surprisingly, there have been only three epidemiological studies conducted since using NAAT, which is a more sensitive test than culture.
The Australian Health In Men (HIM) study by Templeton et al. was the first longitudinal study examining the association between oropharyngeal gonorrhoea and kissing 41. The HIM study recruited 1427 HIV‐negative MSM in Sydney between 2001 and 2007 and they found that both dry and wet kissing with casual partners in the last six months were associated with the incident oropharyngeal gonorrhoea. However, this association disappeared after adjusting other sexual practices including receptive condomless fellatio and insertive oro‐anal contact (that is rimming). In the multivariable analysis, men who often engaged in insertive rimming were 1.6 (95% CI: 1.1 to 2.5) times more likely to have oropharyngeal gonorrhoea than men who never engaged in insertive rimming in the last six months.
The second study by Cornelisse et al. was an age‐matched 1:2 case–control study conducted among 531 MSM in Melbourne in 2015 56. Similarly, the study found that men who kissed their casual partners in the last three months were 2.2 (95% CI: 1.3 to 3.6) times more likely to have oropharyngeal gonorrhoea than those who did not kiss their casual partners in the univariable analysis. However, the authors were not able to perform multivariable analysis due to high collinearity with other sexual practices. Consistent with Templeton et al.'s study, Cornelisse et al.'s study also identified that both insertive rimming and receptive fellatio are risk factors for oropharyngeal gonorrhoea in MSM in the univariable analysis 41.
Both Templeton et al.'s 41 and Cornelisse et al.'s study 56 measured kissing as part of sexual practices and did not investigate kissing without sex as a risk factor. The third study by Chow et al. addressed this concern 57. It was a cross‐sectional study conducted among 3677 MSM in Melbourne in 2016‐2017 that measured male partners in three different categories: (1) kissing‐only partners where men only kissed their partners but did not have sex with them; (2) sex‐only partners where men only had sex with their partners but did not kiss them; and (3) kissing‐with‐sex partners where men kissed and had sex with their partners. Chow et al.'s study defined sex as any oral or anal sexual contacts and the finding showed that both kissing‐only and kissing‐with‐sex partners in the last three months were strongly associated with oropharyngeal gonorrhoea in the adjusted analysis. In addition, the risk of oropharyngeal gonorrhoea increased with an increasing number of kissing‐only and kissing‐with‐sex partners. However, the number of sex‐only partners in the last three months was not associated with oropharyngeal gonorrhoea. This was the first study identified to show kissing in the absence of sex may be an important and neglected risk factor for oropharyngeal gonorrhoea; however, this study did not measure oral sex as a separate sexual act and so could not adjust for it separately.
Although studies have shown that kissing may be a risk factor for oropharyngeal gonorrhoea in MSM, the role of saliva in gonorrhoea transmission is still poorly understood. If saliva can carry infectious gonorrhoea, it is hypothesized that men could acquire oropharyngeal gonorrhoea through kissing by contacting infectious saliva, but it is unclear how much saliva is adequate for gonorrhoea transmission. Moreover, the salivary flow and its production vary between individuals. It is estimated that the salivary flow rate is about 0.3‐0.4 ml per min while unstimulated 58, and the salivary flow rate increases up to 4‐5 ml per min while stimulated such as chewing and eating but no studies have assessed saliva flow rates during kissing or sex 59, 60.
2.3. Oropharyngeal chlamydia
The majority of the oropharyngeal chlamydia infections are asymptomatic in men and therefore their diagnosis primarily depends on asymptomatic screening 61, 62. Unlike oropharyngeal gonorrhoea, age does not seem to be a significant predictor for oropharyngeal chlamydia 62, 63. The HIM Study was a longitudinal study examining the risk factors for oropharyngeal chlamydia transmission in MSM. 63 The HIM study found that men who often engaged in receptive oral‐penile sex with ejaculation were 5.3 (95% CI: 1.7 to 16.7) times more likely to have oropharyngeal chlamydia compared to men who never had receptive penile‐oral sex with ejaculation with their casual partners in the last six months (Table 2) 63. Other activities (for example kissing (both dry and wet kissing), receptive oral‐penile sex without ejaculation and insertive rimming) have found to be not associated with oropharyngeal chlamydia among MSM (Table 2) 63. Similarly, a study conducted in Lima, Peru has shown that there was no significant difference in the prevalence of oropharyngeal chlamydia between MSM who had receptive oral‐penile sex (4.1%) and those who did not (3.4%) 20. However, a strong association between oropharyngeal chlamydia acquisition and history of receptive oral‐penile sex was observed among women 64.
A number of laboratory studies have been undertaken to examine the role of saliva in oropharyngeal chlamydia transmission. Two studies in the 1990s found that saliva has an inhibitory effect against Chlamydia trachomatis 65, 66. Further studies with better technology and a more sensitive diagnostic test are important to validate whether saliva can carry chlamydia to provide a better understanding of transmission.
2.4. Anorectal gonorrhoea
Most men infected with gonorrhoea in the anorectum are asymptomatic; 27 however, among those with symptoms, anal discharge, pain and itching are common. Similar to oropharyngeal gonorrhoea, younger MSM are at higher risk of acquiring anorectal gonorrhoea than older MSM 67, 68. Condomless anal sex is a clear risk factor for anorectal gonorrhoea 67, 69, 70. But other modes of transmission may also occur. For example, an epidemiological study has found that there was no difference in the prevalence of anorectal gonorrhoea between MSM who had receptive penile‐anal sex (8.8%) and those who did not (6.6%) 20. This suggests that other non‐receptive anal sexual intercourses (for example, receptive fingering, receptive fisting (insertion of the hand into the rectum), receptive rimming and dildo insertion) may also be associated with anorectal gonorrhoea (Table 3) 67.
Table 3.
Possible route of transmission | Anorectal gonorrhoea | Anorectal chlamydia |
---|---|---|
Oral infection passing through the gastrointestinal tract to the rectum | Nil | 73, 75, 76 |
Receptive rimming (oral‐anal) | 30, 67 | 67, 72 |
Receptive fisting | 67 | 67 |
Receptive fingering | [30, 67] | 67, 72 |
Receptive of dildos | 67 | 67 |
Saliva use as a lubricate for anal sex | 30 | 72 |
Given that saliva can carry infectious gonorrhoea, it is hypothesised anal sex that involves in saliva (for example use of saliva as a lubricant for anal sex or saliva on a penis before insertion) may be associated with anorectal gonorrhoea (Table 3). A cross‐sectional study of 283 young MSM conducted in San Francisco has shown that about 87% of MSM used saliva as a lubricant for anal sex during their lifetime but only 31% of MSM used it in the last six months 71. Another study conducted among 1312 MSM in Melbourne in 2014‐2015 found that 69% of MSM used saliva as a lubricant for anal sex in the last three months 30. The authors also identified that men who used saliva as a lubricant for anal sex were 2.2 (95% CI: 1.0 to 4.7) times more likely to have anorectal gonorrhoea by culture than those who did not use saliva as a lubricant for anal sex after adjusting for other confounding factors including condom use.
2.5. Anorectal chlamydia
Anorectal chlamydia is primarily transmitted through condomless penile‐anal sex in MSM 22, 67. The HIM study found that receptive fingering, receptive fisting and receptive rimming were risk factors for incident anorectal chlamydia in the univaraible analysis; however, only receptive fingering was an independent risk factor after adjusting for other confounding factors (Table 3) 67. The authors concluded the men who often had receptive fingering were 4.6 (95% CI: 2.3 to 9.3) times more likely to have anorectal chlamydia than those who never had receptive fingering in the last six months. Unlike anorectal gonorrhoea, a Melbourne study by Cornelisse et al. showed that the use of saliva as a lubricant for anal sex is not a risk factor for anorectal chlamydia in MSM 72.
A meta‐analysis published in 2019 has concluded that anal intercourse is associated with anorectal gonorrhoea but not with anorectal chlamydia among women 16. This suggests that the mode of transmission for gonorrhoea and chlamydia is likely to be different and hence it leads to several new hypotheses of anorectal chlamydia acquisition. Animal studies have shown that chlamydia can survive in the gastrointestinal tract suggesting that this may also apply to human 73, 74. New paradigm has been proposed that it is possible oropharyngeal chlamydial infection can pass through the gastrointestinal tract to the anorectum 73, 75, 76. However, further studies are certainly required to confirm this hypothesis.
3. Conclusions
MSM can acquire gonorrhoea and/or chlamydia at the oropharynx and anorectum although the epidemiological evidence suggests the modes of transmission differ. For gonorrhoea, infections at extragenital sites are transmitted through non‐genital contacts such as kissing, rimming and use of saliva in addition to condomless oral or anal sex. For chlamydia, condomless anal sex is the main risk factor. However, the uncertainty about the hypotheses of the route of transmission for gonorrhoea and chlamydia via saliva among MSM should be acknowledged 77. This uncertainty arises in part because infection at multiple sites is common in MSM and multiple sexual practices usually occur during one single sex act 20, 43, making it difficult to clearly delineate which specific sexual practice was responsible for the transmission between anatomical sites 77. Furthermore, existing data regarding chlamydia transmission to extragenital sites are insufficient to draw meaningful conclusions and thus more research is required. Condoms may not necessarily be effective in preventing some extragenital infections 78. Other interventions that target the extragenital site related to its mode of transmission are required 1, 35, 79, 80.
Competing interests
EPFC has received consultant fees from Gilead Sciences and speaker's fee from Seqirus Australia and research grants from Merck Sharp & Dohme outside the submitted work. CKF owns shares in CSL limited which markets Gardasil in Australia.
Authors’ contributions
EPFC wrote the first draft of the manuscript. All authors contributed to the concept, literature search, writing and revisions of the manuscript. All authors critically revised it for important intellectual content and approved the final version of the manuscript.
Acknowledgements
None.
Funding
EPFC was supported by the National Health and Medical Research Council (NHMRC) Early Career Fellowships (1091226).
Chow, E. P. F. and Fairley, C. K. . The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission. J Int AIDS Soc. 2019; 22(S6):e25354
References
- 1. Chow EPF, Grulich AE, Fairley CK. Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV. Lancet HIV. 2019;6(6):e396–405. [DOI] [PubMed] [Google Scholar]
- 2. Jasek E, Chow EP, Ong JJ, Bradshaw CS, Chen MY, Hocking JS, et al. Sexually transmitted infections in Melbourne, Australia from 1918 to 2016: nearly a century of data. Commun Dis Intell Q Rep. 2017;41(3):E212–22. [PubMed] [Google Scholar]
- 3. Mohammed H, Blomquist P, Ogaz D, Duffell S, Furegato M, Checchi M, et al. 100 years of STIs in the UK: a review of national surveillance data. Sex Transm Infect. 2018;94(8):553–8. [DOI] [PubMed] [Google Scholar]
- 4. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235–79. [DOI] [PubMed] [Google Scholar]
- 5. Patton ME, Su JR, Nelson R, Weinstock H. Primary and secondary syphilis–United States, 2005‐2013. MMWR Morb Mortal Wkly Rep. 2014;63(18):402–6. [PMC free article] [PubMed] [Google Scholar]
- 6. Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect. 2004;80(3):174–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Chow EP, Dutt K, Fehler G, Denham I, Chen MY, Batrouney C, et al. Duration of syphilis symptoms at presentations in men who have sex with men in Australia: are current public health campaigns effective? Epidemiol Infect. 2016;144(1):113–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Marrazzo JM, Cates W. Interventions to prevent sexually transmitted infections, including HIV infection. Clin Infect Dis. 2011;53(Suppl 3):S64–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Aral SO. Utility and delivery of behavioural interventions to prevent sexually transmitted infections. Sex Transm Infect. 2011;87(Suppl 2):ii31–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Gabarron E, Wynn R. Use of social media for sexual health promotion: a scoping review. Glob Health Action. 2016;9:32193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Tsoumanis A, Hens N, Kenyon CR. Is screening for chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? A systematic review of observational studies. Sex Transm Dis. 2018;45(9):615–22. [DOI] [PubMed] [Google Scholar]
- 12. Chow EPF, Medland NA, Denham I, Wright EJ, Fairley CK. Decline in new HIV diagnoses among MSM in Melbourne. Lancet HIV. 2018;5(9):e479–81. [DOI] [PubMed] [Google Scholar]
- 13. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population‐level effectiveness of rapid, targeted, high‐coverage roll‐out of HIV pre‐exposure prophylaxis in men who have sex with men: the EPIC‐NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–37. [DOI] [PubMed] [Google Scholar]
- 14. Nwokolo N, Whitlock G, McOwan A. Not just PrEP: other reasons for London's HIV decline. Lancet HIV. 2017;4(4):e153. [DOI] [PubMed] [Google Scholar]
- 15. Johnson Jones ML, Chapin‐Bardales J, Bizune D, Papp JR, Phillips C, Kirkcaldy RD, et al. Extragenital chlamydia and gonorrhea among community venue‐attending men who have sex with men ‐ five cities, United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(14):321–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Lau A, Kong FYS, Huston W, Chow EPF, Fairley CK, Hocking JS. Factors associated with anorectal Chlamydia trachomatis or Neisseria gonorrhoeae test positivity in women: a systematic review and meta‐analysis. Sex Transm Infect. 2019; Epub ahead 16 May 2019. doi: 10.1136/sextrans-2018-053950. [DOI] [PubMed] [Google Scholar]
- 17. Chan PA, Robinette A, Montgomery M, Almonte A, Cu‐Uvin S, Lonks JR, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Chow EP, Williamson DA, Fortune R, Bradshaw CS, Chen MY, Fehler G, et al. Prevalence of genital and oropharyngeal chlamydia and gonorrhoea among female sex workers in Melbourne, Australia, 2015‐2017: need for oropharyngeal testing. Sex Transm Infect. 2019; Epub ahead 21 May 2019. doi: 10.1136/sextrans-2018-053957. [DOI] [PubMed] [Google Scholar]
- 19. Bamberger DM, Graham G, Dennis L, Gerkovich MM. Extragenital gonorrhea and chlamydia among men and women according to type of sexual exposure. Sex Transm Dis. 2019;46(5):329–34. [DOI] [PubMed] [Google Scholar]
- 20. Passaro RC, Segura ER, Perez‐Brumer A, Cabeza J, Montano SM, Lake JE, et al. Body parts matter: social, behavioral, and biological considerations for urethral, pharyngeal, and rectal gonorrhea and chlamydia screening among MSM in Lima, Peru. Sex Transm Dis. 2018;45(9):607–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Cornelisse VJ, Williamson D, Zhang L, Chen MY, Bradshaw C, Hocking JS, et al. Evidence for a new paradigm of gonorrhoea transmission: cross‐sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples. Sex Transm Infect. 2019; Epub ahead 17 April 2019. doi: 10.1136/sextrans-2018-053803. [DOI] [PubMed] [Google Scholar]
- 22. Cornelisse VJ, Sherman CJ, Hocking JS, Williams H, Zhang L, Chen MY, et al. Concordance of chlamydia infections of the rectum and urethra in same‐sex male partnerships: a cross‐sectional analysis. BMC Infect Dis. 2017;17(1):22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Cornelisse VJ, Bradshaw CS, Chow EPF, Williamson DA, Fairley CK. Oropharyngeal gonorrhea in absence of urogenital gonorrhea in sexual network of male and female participants, Australia, 2018. Emerg Infect Dis. 2019;25(7):1373–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, Coates T, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis. 2006;43(10):1284–9. [DOI] [PubMed] [Google Scholar]
- 25. Kinghorn G. Pharyngeal gonorrhoea: a silent cause for concern. Sex Transm Infect. 2010;86(6):413–4. [DOI] [PubMed] [Google Scholar]
- 26. Barbee LA, Dombrowski JC, Kerani R, Golden MR. Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis. 2014;41(3):168–72. [DOI] [PubMed] [Google Scholar]
- 27. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67–74. [DOI] [PubMed] [Google Scholar]
- 28. Rice CE, Maierhofer C, Fields KS, Ervin M, Lanza ST, Turner AN. Beyond anal sex: sexual practices of men who have sex with men and associations with HIV and other sexually transmitted infections. J Sex Med. 2016;13(3):374–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Phang CW, Hocking J, Fairley CK, Bradshaw C, Hayes P, Chen MY. More than just anal sex: the potential for sexually transmitted infection transmission among men visiting sex‐on‐premises venues. Sex Transm Infect. 2008;84(3):217–9. [DOI] [PubMed] [Google Scholar]
- 30. Chow EPF, Cornelisse VJ, Read TRH, Lee D, Walker S, Hocking JS, et al. Saliva use as a lubricant for anal sex is a risk factor for rectal gonorrhoea among men who have sex with men, a new public health message: a cross‐sectional survey. Sex Transm Infect. 2016;92(7):532–6. [DOI] [PubMed] [Google Scholar]
- 31. Reisner SL, Mimiaga MJ, Skeer M, Mayer KH. Beyond anal sex: sexual practices associated with HIV risk reduction among men who have sex with men in Boston, Massachusetts. AIDS Patient Care and STDs. 2009;23(7):545–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Heiligenberg M, Rijnders B, Schim van der Loeff MF, de Vries HJ, van der Meijden WI, Geerlings SE, et al. High prevalence of sexually transmitted infections in HIV‐infected men during routine outpatient visits in the Netherlands. Sex Transm Dis. 2012;39(1):8–15. [DOI] [PubMed] [Google Scholar]
- 33. Lewis D, Newton DC, Guy RJ, Ali H, Chen MY, Fairley CK, et al. The prevalence of chlamydia trachomatis infection in Australia: a systematic review and meta‐analysis. BMC Infect Dis. 2012;12:113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Abraha M, Egli‐Gany D, Low N. Epidemiological, behavioural, and clinical factors associated with antimicrobial‐resistant gonorrhoea: a review. F1000Res. 2018;7:400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Fairley CK, Zhang L, Chow EPF. New thinking on gonorrhoea control in MSM: are antiseptic mouthwashes the answer? Curr Opin Infect Dis. 2018;31(1):45–9. [DOI] [PubMed] [Google Scholar]
- 36. Cornelisse VJ, Chow EP, Huffam S, Fairley CK, Bissessor M, De Petra V, et al. Increased detection of pharyngeal and rectal gonorrhea in men who have sex with men after transition from culture to nucleic acid amplification testing. Sex Transm Dis. 2017;44(2):114–7. [DOI] [PubMed] [Google Scholar]
- 37. Bro‐Jorgensen A, Jensen T. Gonococcal pharyngeal infections Report of 110 cases. Br J Vener Dis. 1973;49(6):491–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Priest D, Read TRH, Chen MY, Bradshaw CS, Fairley CK, Chow EPF. Only recent sexual partners contribute to oropharyngeal gonorrhoea positivity: the number of sexual partners over different time periods as an indicator of gonorrhoea and chlamydia infection duration among men who have sex with men. Sex Health. 2018;15(4):342–9. [DOI] [PubMed] [Google Scholar]
- 39. Wallin J, Siegel MS. Pharyngeal Neisseria gonorrhoeae: coloniser or pathogen? BMJ. 1979;1(6176):1462–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med. 1986;104(5):655–8. [DOI] [PubMed] [Google Scholar]
- 41. Templeton DJ, Jin F, McNally LP, Imrie JC, Prestage GP, Donovan B, et al. Prevalence, incidence and risk factors for pharyngeal gonorrhoea in a community‐based HIV‐negative cohort of homosexual men in Sydney, Australia. Sex Transm Infect. 2010;86(2):90–6. [DOI] [PubMed] [Google Scholar]
- 42. Sackel SG, Alpert S, Fiumara NJ, Donner A, Laughlin CA, McCormack WM. Orogenital contact and the isolation of Neisseria gonorrhoeae, Mycoplasma hominis, and Ureaplasma urealyticum from the pharynx. Sex Transm Dis. 1979;6(2):64–8. [DOI] [PubMed] [Google Scholar]
- 43. Rosenberger JG, Reece M, Schick V, Herbenick D, Novak DS, Van Der Pol B, et al. Sexual behaviors and situational characteristics of most recent male‐partnered sexual event among gay and bisexually identified men in the United States. J Sex Med. 2011;8(11):3040–50. [DOI] [PubMed] [Google Scholar]
- 44. Walker S, Bellhouse C, Fairley CK, Bilardi JE, Chow EP. Pharyngeal gonorrhoea: the willingness of australian men who have sex with men to change current sexual practices to reduce their risk of transmission‐a qualitative study. PLoS ONE. 2016;11(12):e0164033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med. 1974;290(3):117–23. [DOI] [PubMed] [Google Scholar]
- 46. Portnoy J, Mendelson J, Clecner B, Heisler L. Asymptomatic gonorrhea in the male. Can Med Assoc J. 1974;110(2):169–71. [PMC free article] [PubMed] [Google Scholar]
- 47. Ong JJ, Fethers K, Howden BP, Fairley CK, Chow EPF, Williamson DA, et al. Asymptomatic and symptomatic urethral gonorrhoea in men who have sex with men attending a sexual health service. Clin Microbiol Infect. 2017;23(8):555–9. [DOI] [PubMed] [Google Scholar]
- 48. de Voux A, Kirkcaldy RD. Gonococcal infections In: Sexually transmitted infections in HIV‐infected adults and special populations: a clinical guide. Bachmann LH. (ed). Cham: Springer International Publishing; 2017: pp. 69–88. [Google Scholar]
- 49. Fairley CK, Chow EP, Hocking JS. Early presentation of symptomatic individuals is critical in controlling sexually transmissible infections. Sex Health. 2015;12(3):181–2. [DOI] [PubMed] [Google Scholar]
- 50. Fairley CK, Hocking JS, Zhang L, Chow EP. Frequent transmission of gonorrhea in men who have sex with men. Emerg Infect Dis. 2017;23(1):102–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Zhang L, Regan DG, Chow EPF, Gambhir M, Cornelisse V, Grulich A, et al. Neisseria gonorrhoeae transmission among men who have sex with men: an anatomical site‐specific mathematical model evaluating the potential preventive impact of mouthwash. Sex Transm Dis. 2017;44(10):586–92. [DOI] [PubMed] [Google Scholar]
- 52. Chow EP, Lee D, Tabrizi SN, Phillips S, Snow A, Cook S, et al. Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmission. Sex Transm Infect. 2016;92(5):347–9. [DOI] [PubMed] [Google Scholar]
- 53. Chow EP, Tabrizi SN, Phillips S, Lee D, Bradshaw CS, Chen MY, et al. Neisseria gonorrhoeae bacterial DNA load in the pharynges and saliva of men who have sex with men. J Clin Microbiol. 2016;54(10):2485–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Hallqvist L, Lindgren S. Gonorrhoea of the throat at a venereological clinic. Incidence and results of treatment. Br J Vener Dis. 1975;51(6):395–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Willmott FE. Transfer of gonococcal pharyngitis by kissing? Br J Vener Dis. 1974;50(4):317–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Cornelisse VJ, Walker S, Phillips T, Hocking JS, Bradshaw CS, Lewis DA, et al. Risk factors for oropharyngeal gonorrhoea in men who have sex with men: an age‐matched case‐control study. Sex Transm Infect. 2018;94(5):359–64. [DOI] [PubMed] [Google Scholar]
- 57. Chow EPF, Cornelisse VJ, Williamson DA, Priest D, Hocking JS, Bradshaw CS, et al. Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: a cross‐sectional study in men who have sex with men. Sex Transm Infect. 2019; Epub ahead 9 May 2019. doi: 10.1136/sextrans-2018-053896. [DOI] [PubMed] [Google Scholar]
- 58. de Almeida Pdel V, Gregio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9(3):72–80. [PubMed] [Google Scholar]
- 59. Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009;2(3):303–7. [PMC free article] [PubMed] [Google Scholar]
- 60. Karami Nogourani M, Janghorbani M, Kowsari Isfahan R, Hosseini Beheshti M. Effects of chewing different flavored gums on salivary flow rate and pH. Int J Dent. 2012;2012:569327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Peters RP, Nijsten N, Mutsaers J, Jansen CL, Morre SA, van Leeuwen AP. Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in female STD clinic visitors. Sex Transm Dis. 2011;38(9):783–7. [DOI] [PubMed] [Google Scholar]
- 62. Ong JJ, Chow EPF, De Petra V, Williamson D, Pelatosis I, Howden B, et al. Should asymptomatic men who have sex with men be screened for oropharyngeal chlamydia? Clinical outcomes from a cross‐sectional study. Sex Transm Dis. 2018;45(2):103–6. [DOI] [PubMed] [Google Scholar]
- 63. Templeton DJ, Jin F, Imrie J, Prestage GP, Donovan B, Cunningham PH, et al. Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia. Sex Transm Infect. 2008;84(5):361–3. [DOI] [PubMed] [Google Scholar]
- 64. Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, et al. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med. 1985;102(6):757–62. [DOI] [PubMed] [Google Scholar]
- 65. Mahmoud EA, Froman G, Genc M, Mardh PA. Age‐dependent antichlamydial activity of human saliva. A study of infants, children and adults. APMIS. 1993;101(4):306–10. [DOI] [PubMed] [Google Scholar]
- 66. Genc M, Bergman S, Froman G, Elbagir AN, Mardh PA. Antichlamydial activity of saliva. APMIS. 1990;98(5):432–6. [DOI] [PubMed] [Google Scholar]
- 67. Jin F, Prestage GP, Mao L, Kippax SC, Pell CM, Donovan B, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV‐negative homosexual men: the Health in Men Study. Sex Transm Infect. 2007;83(2):113–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Chow EP, Tomnay J, Fehler G, Whiley D, Read TR, Denham I, et al. Substantial increases in chlamydia and gonorrhea positivity unexplained by changes in individual‐level sexual behaviors among men who have sex with men in an Australian sexual health service from 2007 to 2013. Sex Transm Dis. 2015;42(2):81–7. [DOI] [PubMed] [Google Scholar]
- 69. Tomlinson DR, French PD, Harris JR, Mercey DE. Does rectal gonorrhoea reflect unsafe sex? Lancet (London, England). 1991;337(8739):501–2. [DOI] [PubMed] [Google Scholar]
- 70. Young H, Moyes A, McKenna JG, McMillan A. Rectal gonorrhoea and unsafe sex. Lancet (London, England). 1991;337(8745):853. [DOI] [PubMed] [Google Scholar]
- 71. Butler LM, Osmond DH, Jones AG, Martin JN. Use of saliva as a lubricant in anal sexual practices among homosexual men. J Acquir Immune Defic Syndr. 2009;50(2):162–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Cornelisse VJ, Fairley CK, Read TRH, Lee D, Walker S, Hocking JS, et al. Associations between anorectal chlamydia and oroanal sex or saliva use as a lubricant for anal sex: a cross‐sectional survey. Sex Transm Dis. 2018;45(8):506–10. [DOI] [PubMed] [Google Scholar]
- 73. Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun. 2014;82(4):1362–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis. 2013;68(3):88–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Khosropour CM, Dombrowski JC. A web of complexity: untangling the routes of rectal chlamydia acquisition. Sex Transm Dis. 2018;45(8):511–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Rank RG, Yeruva L. An alternative scenario to explain rectal positivity in chlamydia‐infected individuals. Clin Infect Dis. 2015;60(10):1585–6. [DOI] [PubMed] [Google Scholar]
- 77. Spicknall IH, Mayer KH, Aral SO, Romero‐Severson EO. Assessing uncertainty in an anatomical site‐specific gonorrhea transmission model of men who have sex with men. Sex Transm Dis. 2019;46(5):321–8. [DOI] [PubMed] [Google Scholar]
- 78. Hui B, Fairley CK, Chen M, Grulich A, Hocking J, Prestage G, et al. Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model. Sex Transm Infect. 2015;91(5):365–9. [DOI] [PubMed] [Google Scholar]
- 79. Chow EP, Howden BP, Walker S, Lee D, Bradshaw CS, Chen MY, et al. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomised controlled trial and an in vitro study. Sex Transm Infect. 2017;93(2):88–93. [DOI] [PubMed] [Google Scholar]
- 80. Chow EPF, Maddaford K, Trumpour S, Fairley CK. Translating mouthwash use for gonorrhoea prevention into a public health campaign: identifying current knowledge and research gaps. Sex Health. 2019; Epub ahead 17 May 2019. doi: 10.1071/SH18237. [DOI] [PubMed] [Google Scholar]